Saying she's ready for a break, Leslie Alexandre is stepping down as CEO of the North Carolina Biotechnology Center.
Trellis Bioscience has appointed Brian C. Cunningham as CEO.
NitroMed has named CFO Kenneth Bate as CEO, succeeding interim CEO Jerry Karabelas. The company also named James Ham CFO.
BioProcessors has appointed Jonathan Rennert as president and CEO.
Takeda Global Research & Development Center has named Mehmood Khan, M.D., president.
Mazal Plant Pharmaceuticals has appointed Stanley Fass as interim president and director.
Jeffrey M. Jonas, M.D. will join Isis Pharmaceuticals on February 1 as executive vice president.
Pharmasset has named M. Michelle Berrey, MD, as chief medical officer and William T. Symonds, PharmD as vice president, clinical pharmacology.
Synta Pharmaceuticals announced the following appointments: Art McMahon has been named vice president of human resources; Andrew Sonderfan has been appointed vice president, pre-clinical safety assessment and Rob Kloppenburg has joined the company as vice president, investor relations and corporate communications.
Kirk T. Williamson joined ViaCell as vice president of marketing.
Neuroptix announced that Evan Sherr has signed on as vice president, product management, and Vincent Valvo is the new vice president, engineering and product development.
Oncolytics Biotech has named Mary Ann Dillahunty as vice president, intellectual property.
OMRIX Biopharmaceuticals has appointed Kevin Rakin and Philippe Romagnoli as new members of the board of directors; promoted Mike Burshtine to executive vice president and CFO and Nissim Mashiach to executive vice president and COO.
CytoCore has added Dr. Stephen Raab to its medical advisory board.
Transgenomic has accepted Collin J. D'Silva's resignation as a member of the board of directors, including his position as chairman of the board and secretary of the company.
Carla A. Hills has been appointed to Gilead Science's board of directors, bringing the number of directors to 10.
Biomira announced that Eric E. Baker retired from the company's board of directors.
Senesco Technologies has named Jack van Hulst to the board.